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Abstract
We extend the image-to-image metamorphosis into constrained longitudi-
nal metamorphosis. We apply it to estimate an evolution scenario, in patients
with acute ischemic stroke, of both scattered and solitary ischemic lesions vis-
ible on serial MR perfusion weighted imaging from acute to subacute stages.
We then estimate a patient-specific residual map that enables us to capture
the most relevant shape and intensity changes, continuously, as the lesion
evolves from acute through subacute to chronic timepoints until merging
into the final image. We detect areas with high residuals (ie. high dynamics)
and identify areas that became part of the final T2-w lesion obtained at ≥ 1
month after stroke. This allows the investigation of the dynamic influence
of perfusion values on the final lesion outcome as seen on T2-w imaging.
The model provides detailed insights into stroke lesion dynamic evolution in
space and time that will help identify factors that determine final outcome
and identify targets for interventions to improve outcome.
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1. Introduction:
Stroke is the third leading cause of death in industrialized countries and
a major cause of death worldwide. Ischemia –the commonest type of stroke–
results from disruption of blood flow within the brain caused by occlusion of
an artery. Efforts to improve the treatment of ischemic stroke target ‘brain
tissue at risk of infarction’ (the penumbra) that can revert to a normal state
following successful recanalization of the occluded artery within the first few
hours after onset (Wardlaw, 2010). Multi-modality brain imaging is widely
used in acute stroke management for diagnosis, prognosis and treatment
planning. In particular, diffusion-weighted imaging (DWI) and perfusion-
weighted imaging (PWI) are frequently used to detect early ischemic changes
and distinguish between permanently damaged and salvageable tissues. How-
ever, while medical imaging has improved our understanding of stroke for the
last decades, it is still not possible to determine the ‘best’ treatment in any
one individual patient (Wardlaw et al., 2012). One reason for that is the
wide spectrum of stroke lesion patterns and the lack of understanding of
factors governing lesion evolution. Particularly, stroke lesions are frequently
multicomponent, appear and disappear, distort adjacent tissues and have ill-
defined boundaries (Rekik et al., 2012). A second reason is the wide use of
basic volumetric analysis and thresholding tools for assessing a stroke lesion
and selecting patients for clinical trials (Hacke et al., 2005; Furlan et al.,
2006; Davis et al., 2008). These basic quantitative techniques fundamentally
limit our scope for examining stroke dynamics as they do not capture the
direction, locality or the speed of stroke lesion evolution.
This suggests the need for better methods to overcome the limitations
of these techniques and accurately characterize stroke lesion dynamics. As
highlighted in the review paper (Rekik et al., 2012), no patient-specific dy-
namic models had been developed to map in detail the kinetics of the lesion
evolution and to estimate the spatiotemporal deformations that ischemic tis-
sue undergoes. Recent work by (Rekik et al., 2013) began the exploration of
advanced spatiotemporal (4D) models for studying the dynamics of stroke
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evolution in longitudinal data. The applied current deformation model en-
abled the identification of areas of contraction and expansion in stroke lesion
surfaces, which allowed us to investigate correlations between perfusion and
diffusion lesion surface evolutions (Rekik et al., 2013). Although this model
proved to be a mathematically robust representation of the lesion surface, it
could not incorporate image intensity measures in its abstract mathematical
framework. Hence, there was no possibility of using this model to study the
effects of DWI or PWI or other tissue parameter values on lesion dynamics.
Furthermore, it was not suitable for lesions where the number of components
varied with time. However, scattered multicomponent lesions and variable
patterns of perfusion and diffusion abnormality progression are very common
(84% of our cohort) (Ogata et al., 2011).
To partly overcome these limitations, we used a more versatile approach,
the metamorphosis model –introduced by (Trouve´ and Younes, 2005), which
handles both multi-component and solitary lesions and incorporates gray-
scale intensities into the 3D image evolution. To examine the influence of
perfusion values on final tisse outcome, we extend the work presented in
(Garcin and Younes, 2005) from two-image based metamorphosis into time-
series based longitudinal metamorphosis and introduce a new constraint on
the velocity path to force its regularity in time. We identified one recent pa-
per that addressed longitudinal image evolution using metamorphosis. Hong
et al in (Hong et al., 2012) adapted the work of (Niethammer et al., 2011)
by proposing a metamorphic geodesic regression using appropriate averaging
of independent pairwise metamorphoses. In this paper, we present a differ-
ent and more compact formulation for longitudinal metamorphosis using an
ordered set = = {I0, I1, , IN} of N images. Unlike (Hong et al., 2012), our
approach does not require a pairwise estimation of N + 1 metamorphoses
using geodesic regression. Instead, the method estimates a single metamor-
phosis that exactly meets all the intermediate images (observations) in =,
while enforcing regularity in time for the estimated velocity field (Figure 1).
The remainder of this paper is structured as follows. In section 2, we
will describe the image-to-image formulation of the metamorphosis theory
and its extension to longitudinal data. In section 3, we present the results of
longitudinal metamorphosis to both synthetic images and perfusion ischemic
lesion and investigate the relation of the metamorphic residual to the final T2-
w lesion boundary. Finally, we present a critical overall analysis, presenting
3
the major findings and limitations of our model and revealing new avenues
for exploration in ischemic stroke.
Figure 1: Comparison between metamorphic regression scheme presented in
(Hong et al., 2012) (a) and our longitudinal metamorphosis (b). The red
bold line in (a) represents the metamorphic regression line determined by
pairwise metamorphoses between the baseline image I(t0) and the images Ii.
Each individual metamorphosis is defined by the initial momentum of the
geodesic shooting. In (b), the estimated longitudinal metamorphosis path Jt
morphs the baseline image successively into I1, I2, I3 till merging with the
final image I4. To avoid the velocity jumps we force the estimated velocity
to be continuous in time at the observation timepoints {t0, t1, . . . }.
2. Methods:
2.1. Image-to-image metamorphosis:
2.1.1. Prior to the metamorphosis era: the diffeomorphic era
The serial medical imaging and the increasingly acquired datasets to
study changes in anatomy and brain diseases evolution has triggered the
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development of compelling mathematical frameworks based on deformations
(Klein et al., 2009). A specific category of spatial deformations has spanned
the attention of researchers in this field: diffeomorphisms (smooth deforma-
tion with a smooth inverse). These were largely used in different registration
models (Allassonnie`re et al., 2005; Beg et al., 2005; Holland and Dale, 2011;
Klein et al., 2009) and became a part of the classical deformable template
theory –especially after the establishment of the Large Deformation Diffeo-
morphic Metric Mapping (LDDMM) –pioneered by (Dupuis et al., 1998;
Trouve´, 1995, 1998). The metamorphosis theory is built upon the LDDMM
framework which is based on the idea of a diffeomorphic metric. This metric
is a distance on the object space –seen as a Riemannian manifold– which
results from the transportation of a metric on the group of diffeomorphisms
by a group action. This defines a distance between two objects through
the geodesic diffeomorphic path which connects one to the other. In the
following, we will only consider objects which are images. The estimated dif-
feomorphic transformation g1 connects a source image I0 to a target image
I1 as follows: I0 ◦ g−11 = I1. The central idea of LDDMM is that g1 is the
mapping at time 1 of a deformation path. What drives the evolution of this
transformation from g0 to g1 is the flow equation: given vt(g(t)) a velocity
vector field {
dg(t)
dt
= vt(g(t))
g0 = id
(1)
where id is the identity map.
However, a major shortcoming of the diffeormophic metric is that it does
not allow variations in the topology of the deformed object. For this reason,
it is commonly used to study changes in anatomical structures (as connected
sets remain connected and disjoint sets remain disjoint) rather than brain
lesions that may take dissimilar forms and undergo a topology change (such
as the appearance of new disconnected sets of ischemic regions in stroke or the
merging of different sets into a bigger one). To overcome this shortcoming,
a different mathematical formulation introduced a slight modification in the
idea of the diffeomorphic metric (Trouve´ and Younes, 2005). This led to the
definition of a new metric: the metamorphic metric.
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2.1.2. The metamorphosis theory:
Proposed by (Trouve´ and Younes, 2005), metamorphosis is an efficient
non-linear registration method that aligns two images by jointly estimating
an optimal velocity deformation vector field vt and an optimal intensity scalar
field It. The idea of metamorphosis stems from including the infinitesimal
variation of the grey level of the image in the metric used to estimate the
geodesics of deformations accounting for intensity change and producing the
metamorphic metric. The definition of this metric requires the use of appro-
priate spaces to which images, forces acting on them, and velocities driving
the evolutions of the baseline image towards the target images belong. The
mathematical framework for metamorphosis is composed of the three main
components:
• Image: an image I is an element of the square integrable set of func-
tions M = L2(Ω) considered as a Riemannian manifold (the object space)
with Ω the support of I. A curve (t 7→ It, t ∈ [0, 1]) on M is the evolution
path of a base line image I0. M is equipped with the usual metric on L
2.
• Action (force): an action g ∈ G is a diffeomorphic transformation
which acts upon the object space M . In the realm of a classical diffeomorphic
deformation theory, the action g is associated to the velocity v through the
flow equation (Eq (1)). A curve (t 7→ gt, t ∈ [0, 1]) on G acting on I ∈ M
describes a path of deformation morphing I over the time interval [0, 1].
• Velocity: for all t ∈ [0, 1], the velocity field vt belongs to the vector
space V , which is the tangent space to the action group G. We adopt similar
construction as in (Beg et al., 2005) for the velocity vector space V on which
smoothness constraints are placed to ensure the existence of optimal smooth
solutions in the space of diffeomorphisms for the flow equation (Eq 1). We
endowed the velocity vector space V with an inner product < ., . >V defined
through a differential Cauchy-Navier type operator L (with adjoint L†) given
by: < f, g >V =< Lf, Lg >L2=< L
†Lf, g >L2) where < ., . >L2 is the
standard L2 inner-product for square integrable vector fields on M and the
Cauchy-Navier differential operator as presented in (Beg et al., 2005) L =
(−α∇2 + γ)Id (Id is the identity matrix). Thus, the required smoothness of
the deformations is specified by the norm of the space V of smooth velocity
vector fields through L.
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As defined by (Trouve´ and Younes, 2005), a metamorphosis is a pair of
curves ((g(t), I(t)), t ∈ [0, 1]) on the product space M = G × M , with
g(0) = id. The effective metamorphosis path J(t) on M is defined as a
combination of the action deformation path g(t) and the image path I(t)
which is the residual of the deformation on M : J(t) = g(t) · I(t). All details
metamorphosis are available in (Trouve´ and Younes, 2005).
As shown in (Garcin and Younes, 2005), the optimal metamorphosis
curves ((g(t), I(t)), t ∈ [0, 1]) –morphing the source image I0 into the target
one I1– are estimated by minimizing the cost functional U(I, v):
U(I, v) =
∫ 1
0
|v|2V dt+
1
σ2
∫ 1
0
∣∣∣∣dI(t)dt +∇It.vt
∣∣∣∣2
L2
dt (2)
The term ∇It.vt represents the spatial variation of the moving image It in
the direction vt. Furthermore, the moving intensity scalar field It is defined
under the action of the diffeomorphism gt on a baseline image I0 : It = gt.I0.
This nicely brings us to the diffeomorphic flow equation (Eq 1) that is driven
by a sufficiently smooth deformation vector field to estimate (Beg et al., 2005;
Trouve´, 1998). All the previous equations have the fundamental property
to remain geodesic equations in the image manifold M . Their solution is
sought through a minimization algorithm, which provides an efficient and
robust estimation of intensity variation and diffeomorphisms –in case of large
deformations (Trouve´ and Younes, 2005).
This formulation unifies in a common mathematical framework intensity
change and deformation. The residual of the deformation term |δ(t)|2I(t) =
|dI(t)
dt
+ ∇It.vt|2L2 undertakes that the metamorphosis scheme includes the
variations in the image evolution path I(t) induced by the deformation field
vt, thereby it can be viewed as a condensed form that sums up both variations
in intensity and shape.
As we need to minimize this energy for image matching, a discretiza-
tion step in the time and space domains is required. We reproduce the
discretization scheme proposed by (Garcin and Younes, 2005) for the image-
to-image metamorphosis where we approximate the term ∇It.vt by (I(t +
1, x+ v(t, x))− I(t, x)) as follows:
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lim
→0
I(t+ , x+ v(t, x))− I(t, x)

=
∂I(t, x)
dt
+
∂I(t, x)
dx
.v(t, x) (3)
Next, we discretize the energy functional in the discrete time domain of
evolution [0, T ] (with the size of a timestep ∆t being such that T = n×∆t)
and in the image space domain (a grid). We use a trilinear interpolation
proposed by (Garcin and Younes, 2005) to define real values for x+ vt(x):
ΓvtIt+1 : x ∈ Ω→ Γ(It+1)(x+ vt(x)) = I(t+ 1, x+ v(t, x)) ∈ R .
By applying the trilinear operator Γ to It+1(x+ vt(x)), we get:{
U(I, v) =
∑T−1
t=0 |vt|2V + 1σ2
∑T−1
t=0
∑
x∈Ω |Γ(It+1)(x+ vt(x)) +∇It.vt|2L2
vt0 = vt1and vT−1 = vT
(4)
We initialize the image evolution path from the source I0 to the target
image I1 trough piece-wise trilinear interpolation (fixed boundary conditions
for exact matching): I(t) = (1 − t)I0 + tI1; with t ∈ [0, T ]. Ultimately, the
minimal metamorphosis path composed of both optimal image path (t 7→
It, t ∈ [0, 1]) and the associated diffeomorphic path (t 7→ gt, t ∈ [0, 1])
is calculated using the metamorphosis energy gradients (∇ItU,∇vtU) in a
standard alternating steepest gradient descent algorithm:
∇ItU(I, v) =
2
σ2
It − ΓvtIt+1 + ΓTvt−1(Γvt−1It − It−1) (5)
∇vtU(I, v) = 2vt +
2
σ2
[(Γvt∇xIt+1)T (ΓvtIt+1 − It)] (6)
2.2. Constrained longitudinal metamorphosis using N images:
Now we will present the generalization to a set of time dependent ob-
servations. We aim to estimate a metamorphosis (w.r.t the metamorphosis
metric) for which we constrain the velocity vector field (vt)t∈[0,1] to be con-
tinuous in time in particular at the observation timepoints. This is based on
similar equations as before and the energy to minimize becomes:
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{
U(I, v) =
∑T−1
t=0 |vt|2V + 1σ2
∑T−1
t=0
∑
x∈Ω |Γ(It+1)(x+ vt(x)) +∇It.vt|2L2
vt0 = vt1 vT−1 = vT and vt−1 = vt = vt+1for t ∈ {1, . . . , T − 1}
(7)
where (vt)t∈[0,1] is continuous in time. We enforce the continuity of the
velocity vector field so that the whole path is continuous in time. This is
done as follows: for any observation timepoint t = tobs:
vtobs = v
+
tobs
= v−tobs (8)
We choose a small time discretization step between the observations for
this definition of regularity in time to be valid. This constraint forces the
estimated metamorphosis to follow a relevant path (w.r.t. our application)
and makes it differ from concatenated paths as illustrated in Figure 2.
In order to minimize this energy and get the longitudinal metamorphosis
using N images = = {I0, I1, , IN}, we exactly follow the steps of the gradient
descent pipeline using equations 5-6, except that we modify two steps. In first
step, we initialize image evolution path from the source image I0 to the target
image IN trough piece-wise trilinear interpolation (fixed boundary conditions
for exact matching). However, we force the algorithm to exactly go through
all observations (time-series images) by keeping the observations unaltered
and only updating the intensity path connecting them. The second change is
that we impose a time-continuity constraint on the estimated velocity which
forces relevant final deformation maps in a way that would better capture
the dynamics of the lesions.
3. Material:
Patient recruitment [10 patients]: We test the metamorphosis model on
10 representative patients from a study of serial MR imaging in hyperacute
stroke, representing a range of stroke severity (mean ± std dev.): (NIHSS =
12.6±8.9), age (74±9.47 years) and acute mean transit time (MTT) volume
(1.78± 1.23 105 mm3). We include patients who had PWI images at around
5 hours, the second at around 5±1 days and the third at 10.5±2.5 days after
9
Figure 2: Enforcing the continuity in time of the estimated velocity field
(vt) at observation timepoints. (Top) For a fixed voxel x in the image, we
notice that the velocity curve vt is discontinuous at observation timepoints
tobs as both the red and blue curves are not “glued” together. We enforce the
continuity at the observation timepoints by associating a new value to vobs at
tobs that is equal to the velocity value at t
−
obs then we update t
+
obs to establish
the equality between the three discrete points in time. This generates a new
velocity curve (in green) that is continuous in time.
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stroke and T2-weighted images lesion at ≥ month after stroke. Furthermore,
we have checked that swelling in the recruited patients did not distort DWI
lesion boundary as it can mislead the result interpretations.
MR imaging and pre-processing steps: All MR images were acquired using
a GE Sigma LX 1.5-T MR scanner (General Electric, Milwaukee, Wiscon-
sin) with a birdcage quadrature coil and a standardized protocol for acute
stroke. The spin-echo echoplanar imaging diffusion tensor axial sequences
and dynamic susceptibility contrast echoplanar imaging PWI had 15 axial
slices each of 6mm thickness with an interslice gap of 0.97mm and an imag-
ing matrix 128 × 128 encompassing a 240 × 240mm field of view. MTT
perfusion maps were generated using PWI data, full details of the image ac-
quisition and processing protocol have been described previously in Rivers
et al. (2007). The MTT and final follow-up T2-weighted images (at ≥ 1
month after stroke) were co-registered using a 3D affine transformation and
their corresponding visible lesions manually delineated on every slice by an
expert. Similarly the perfusion series were registered to the diffusion series
(Bastin and Armitage, 2000). We used affine registration to compensate for
these effects and account for patient motion, similar procedures have been
applied elsewhere (Huang et al., 2008). Normalized mutual information was
used as a similarity measure since the contrast between the diffusion baseline
image and other images is dependent upon the direction of diffusion weight-
ing –likewise the perfusion series before and after the arrival of gadolinium
contrast.
4. Results:
4.1. Comparison between the proposed longitudinal metamorpho-
sis and independent metamorphoses:
In this section, we compare the synthetic results of our method with
respect to those of a modest concatenation of individual metamorphoses.
Note that this concatenation does not make any assumption on the continuity
of the deformation field so that it will most probably be discontinuous at the
observation time points. This problem should be avoided by our method
and therefore better fit the real behaviour of the lesion. To perform this, we
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introduce a synthetic example where the comparison is easier and preliminary
observations are made.
We have tested the proposed longitudinal metamorphosis which is the so-
lution of an energy minimization under constraint on synthetic images (two
small spheres merging into one sphere then expanding into a bigger one,
Figure 3). Our approach is different from the estimation of successive inde-
pendent metamorphoses from image at t1 to image at t2 then from image
at t2 to image at t3 etc, then gluing these bits all together to build the
longitudinal metamorphosis scenario. More importantly, we show in Fig-
ure 3 successive snapshots of the estimated velocity field magnitude for the
proposed constrained longitudinal metamorphosis that goes through three
synthetic images (Figure 3-B, first row) and for an image-to-image metamor-
phosis concatenating two independent metamorphoses (one morphing image
1 into image 2 and a second one morphing image 2 into image 3) (Figure 3-B,
second row). The visual comparison of both evolution scenarios shows a lack
of a transition phase between metamorphosis I and metamorphosis II: the
concatenation process of two independent metamorphoses create an abrupt
change in the estimated velocity field. However, the constrained longitudinal
metamorphosis includes an in-between transition phase between the pairs of
evolution {image 1→ image 2} and {image 2→ image 3} at the observation
timepoint t2 (outlined in red in Figure 3). Therefore the evolution of the set
of synthetic images seems more natural in the first estimated longitudinal
metamorphosis scenario.
4.2. Metamorphic longitudinal matching applied to perfusion MR
images of stroke:
For every patient, we estimated a longitudinal metamorphosis of MTT
lesion from acquisition timepoint t1 to t3. Both velocity and intensity paths
are presented in Figure 4. We empirically set the trade-off parameter σ such
as 1
σ2
= 0.001 for all patients. We chose Cauchy-Navier differential operator
L to provide greater smoothing of our data, justified in our study since we
focus on obtaining a quantified estimate of the dynamics of ischemic lesion
spatial margins. We set α = 0.01 and γ = 0.001 as suggested by (Beg et al.,
2005).
We used the proposed longitudinal metamorphosis to exhibit and examine
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a single map (here residual map) generated for every patient. A significant
property of the estimated residual map is that it condenses in one image both
the magnitude of the deformation and intensity variation in the lesion during
its metamorphosis (see Fig.5), thereby giving insights into the kinetic and
photometric dynamic behavior of the perfusion lesion. We would also like to
highlight that both residual and deformation maps were generated using the
estimated in-between-observations It and vt evolution paths while excluding
the observation timepoints (our fixed boundaries) since the lesion evolution
in space and time is mainly defined by these in-between estimated paths.
For each patient, we reconstruct the normalized residual map (rMap) as:
For x ∈ Ω, rMap(x) =
T−1∑
t=0
|Γ(It+1)(x+ vt(x))− It(x)|2L2 (9)
Then we normalize it between 0 and 1. The estimated residual maps
quantify the variation in perfusion values inside the lesion under the action
of the estimated deformation field. Therefore, residual areas with highest
values mark where the most relevant dynamic change in both intensity and
shape takes place. To detect these areas with highest MTT variation from t1
to t3, we define an automated threshold as the mean value of rMap. Then, we
generate a new normalized thresholded rMap by including all the voxels with
values above this threshold. Figure 5 visualizes the steps of the algorithm for
every patient in our cohort. Finally, we compute the volumetric overlap (in
%) between the thresholded residual map and T2-w lesion w.r.t final T2-w
volume. This volumetric overlap indicates how much of the final T2-w lesion
is occupied by the thresholded residual map.
Using Eq. (9), the residual map includes the most relevant lesion changes
in shape and intensity from t1, to t2 then to t3; however, it does not inform us
about the direction in which the perfusion change is going (positive direction
ie. increasing values or negative direction ie. decreasing values). To inter-
pret the thresholded rMap with regard to the direction of perfusion values
variation –while only focusing on the acute and late perfusion changes, we
generated a signed MTT map defined as the difference image between MTT
image at t3 and MTT at t1:
For x ∈ Ω, map∆MTT (x) = MTTt3(x)−MTTt1(x).
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Then, we mark areas in the thresholded residual map with negative (blue)
and positive (red) map∆MTT values. This generates a signed thresholded
residual map (Figure 6) that allows us to simultaneously look at perfusion
areas that underwent the highest intensity and deformation changes with
distinction of areas where MTT values decreased from t1 to t3 (negative
map∆MTT values) or increased from t1 to t3 (positive map∆MTT values). Pos-
itive regions in the signed rMapthresholded represent ‘extreme’ areas where
the perfusion abnormality has worsened. In the other hand, negative regions
highlight areas where the blood flow bettered.
Remark: The signed thresholded residual maps do not exceed the bound-
aries of the manual outlines of MTT lesions at the three acquisition time-
points. We also would like to point out that one could use equation 9 without
the L2 norm to generate the thresholded residual map. However, we preferred
to restrict our analysis on only immediate change from acute (at t1) to final
dead tissue (at t3) and not to consider the intermediate change that is gov-
erned by many unknown variables and pathophysiological ‘laws’. Comparing
only the first to final tissue states is a common clinical assessment routine.
We used it to shed light on the thresholded residual map.
4.3. Exploring the predictive potential of MTT maps using meta-
morphic residual maps:
There exists a wide variation between patients in the total volumetric
overlap between the thresholded metamorphic residual map and final T2-w
lesion between patients (mean = 45.4%, standard deviation = 28% median
= 32.8%). Positive skewness (Figure 7, box 1) suggests that most patients
deviate from the median with a wider range of volumetric overlap. This
shows that the thresholded residual map marking abnormal perfusion areas
with highest change in shape and intensity identifies relatively large dead
areas within the T2-w lesion.
The most dynamic part of PWI lesion where perfusion was improving
(ie negatively signed thresholded residual map) overlapped with the final
T2 volume with range from 0 to 67%, mean = 26.1%, standard deviation =
19.3%, median = 17.1% in our cohort. This shows that the acute-subacute
improvement of the hemodynamics of the abnormal perfusion area does not
necessarily imply that it will certainly end up outside the final T2-lesion. The
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Figure 6: Signed thresholded residual maps in three representative patients.
Top row: same axial slices of one MTT lesion (outlined in blue) at three
successive acquisition timepoints for three patients. Bottom row: (a) the
final T2-w image where the final dead tissue is manually outlined in red. (b)
Signed thresholded residual map (red color for positive values and blue color
for negative values) overlaid with final T2-w image. Both images (a) and (b)
represent the same axial slice.
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negative overlap was evenly split at the median of the data (ie. zero skewness,
Figure 7-box 2). Only Figures 7-box 2 and 6 show that the majority of
areas in the rMapthresholded are positively signed (red areas Figure 6), ie.
with worsened blood flow. This indicates that the thresholded residual map
contains areas whose MTT values increased from t1 to t3, thus, identifying
areas that are more likely to shift into an irreversible state of tissue death.
Figure 7: Boxplot illustrating the skewness in our cohort for the volumetric
overlap between thresholded metamorphic residual map (rMapthresholded) and
final T2-w lesion (box 1). Box 2 shows the distribution of the volumetric
overlap between negatively signed rMapthresholded and final T2-w lesion. The
red line represents the median value of the volumetric overlap. The lower
boundary of the blue box represents the 25 percentile and the upper bound
represents the 75 percentile. The upper (vs. lower) horizontal line denotes
the 90 (vs. 10) percentile.
5. Discussion and conclusions:
In the present work, we proposed a trivial extension of the work of (Trouve´
and Younes, 2005) and (Garcin and Younes, 2005) for the image-to-image
metamorphosis theory into a constrained longitudinal metamorphosis that
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passes exactly through the true observations, while forcing the geometric
evolution to be continuous in time. We applied it to serial perfusion im-
age data obtained in the acute to subacute stages in patients with ischemic
stroke. This provided a robust, sophisticated mathematical tool to extract
both dynamic and intensity features from the perfusion lesion summarised in
the intensity variation and shape deformation residual map. We then used
a static T2-w image at ≥ 1 month after stroke to determine the reversibility
of the metamorphic residual of the perfusion lesion. We aimed to provide a
sophisticated method, that is blind to clinical features (eg: site of occlusion,
stroke severity score, etc), for evaluating the effect of variations in cerebral
perfusion on tissue outcome. We hypothesized that the hypoperfused areas
that underwent the most shape and intensity variation a) would have been
exposed to the largest differences in perfusion values and b) the values would
be consistent between tissues that behaved similarly.
We demonstrated that the estimation of longitudinal metamorphic resid-
ual maps is a promising tool in tracking the spatiotemporal changes in lesion
shape and intensity. This overcomes major limitations of the commonly
used 2D or 3D voxel-based or volume-subtraction methods that do not allow
the estimation of dynamic characteristics of lesion progression or regression
(Beaulieu et al., 1999; Karonen et al., 2000; Kluytmans et al., 2000; Rekik
et al., 2012; Wittsack, 2002). Our model is fully automated and does not
require any manual landmark matching. It is also generic so could be applied
to other medical applications based on serial imaging.
Using the automatically thresholded residual map, we showed that the
amount of variation in MTT lesion shape and intensity identified a large
portion of tissue that is irreversibility damaged. Thus, the MTT map showed
promise for identifying dead tissue margins and tissue that survived, although
there was substantial variation in the individual perfusion values. This means
that it is difficult to identify any one MTT value that differentiates tissue
destined to die from tissue that will survive between patients, as it is the
dynamic properties of the MTT lesion that seem to determine tissue fate. The
present model could be used to tailor more sophisticated models to predict
tissue fate using the estimated evolution of the perfusion lesion shape and
intensity. It could also be used to examine other factors that may influence
ischemic lesion outcome such as blood pressure or pharmacological treatment.
The signed residual maps showed that most of the abnormal perfusion tissue
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in which MTT values increased (with positive map∆MTT values ie. worsening
of blood flow) belonged to the final T2-w boundary. However, some portions
(negative overlap: mean = 26.1%, standard deviation = 19.3%) of the acutely
ischemic tissue whose MTT values decreased (ie. better blood flow) also
ended up as dead tissue. This highlights the potential for the most active
positive residuals to be used in further predictive models to identify the
boundaries of the final dead tissue.
One of the key clinical findings of our approach revealed the absence of a
single threshold for rMap that fitted all patients. Patient-specific thresholds
were automatically defined using the metamorphic residual maps. These
thresholds involved both variation in MTT perfusion values and lesion shape
change as the lesion evolved [t1, t3] – showing that the evolution of ischemic
but still viable tissue is patient-specific (and not dataset-specific). This is
consistent with a recent summary (Dani et al., 2012) which did not identify
a specific threshold or range of perfusion values that clearly discriminated
tissue fate. Our method may have allowed us to capture some of the highly
dynamic nature of perfusion values in individual parts of ischemic lesions for
the first time in humans, as for example, have been shown in experimental
models due to spreading depolarizations (Strong et al., 2007).
Several longitudinal studies have previously evaluated lesion evolution us-
ing standard thresholding and volumetric analysis techniques (Beaulieu et al.,
1999; Karonen et al., 2000) to assess the combined role of perfusion or dif-
fusion lesion in determining the degree of tissue survival or death. However,
they did not explore the dynamic characteristics of lesion boundary evolu-
tion and their relation to its hemodynamics. A recent study (Carrera et al.,
2011) noted that MTT perfusion values –outside and also within the DWI
lesion– could be used to improve the identification of final infarct boundary.
Two different perfusion thresholds were distinctively identified for two dif-
ferent datasets. Interestingly, in our study, we showed that perfusion values
and spatiotemporal changes from acute to later stages are patient-specific
and not dataset-specific, thereby demonstrating that perfusion thresholds or
thresholds that depend on perfusion values are specific to each patient and
not to a particular dataset.This accumulating evidence mitigates against the
likelihood of finding universal and consistent perfusion values that identify
at risk of infarction, dead and oligaemic tissue in all patients and is expected
to change the course of future clinical trials and patient selection criteria
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towards individualized medicine.
Identifying the shift in tissue abnormality, from being ‘reversible’ to be-
ing ‘irreversible’ in both space and time, is still one of the main challenges in
stroke. The emergence of methods for dynamic modelling in stroke research
shows potential for advancing our understanding of ischemic tissue dynam-
ics. The key to a nuanced understanding of how perfusion values influence
the spatial extent of tissue that will ultimately die or survive lies in refin-
ing the perfusion hypothesis (Butcher et al., 2005). This hypothesis states
that abnormal perfusion areas where blood flow improved between acute and
subacute stages will recover and those where blood flow worsened have the
greatest likelihood to be irreversible. However, while this may be generally
true, we have noticed in our study that there is substantial variation in per-
fusion values in space and time that limit use of specific perfusion values in
prediction of tissue fate. Exposing the ‘laws’ that govern the hemodynamics
of stroke would revolutionize stroke research. This may be achievable by
using a more sophisticated version of longitudinal metamorphosis (eg: by
including tissue heterogeneity or other perfusion parameters or site of occlu-
sion) that we have demonstrated is now feasible.
Our study has some limitations. We did not account for differences in
perfusion values between gray and white matter as ischemic lesions are dif-
ficult to segment into grey and white matter at present (Koga et al., 2005).
We checked visually that the included patients did not have large amounts of
lesion swelling as this could bias assessment of the final dead tissue volume.
Accounting for acute swelling and late ex vacuo effect using more sophisti-
cated registration algorithms would increase the accuracy of our method but
validated techniques are not currently available. Our sample size was small
– we chose these 10 patients to represent a range of lesion morphologies and
changes over time to illustrate that the method was feasible and determine
its potential for displaying dynamic stroke lesion pathophysiology. It was not
our intention to provide definitive perfusion values or to examine how, for
example perfusion values might influence diffusion values, or the impact of
clinical variables. This is is subject to future work in larger datasets with a
more personalized version of the implemented metamorphosis method.
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6. Conclusion:
We used longitudinal metamorphosis to track the evolution of perfusion
abnormality in stroke using time-series imaging. This model provides novel
ways to identify the most active changes in ischemic lesion hemodynamics
using signed residual maps and we believe will be valuable in future stroke
research to clarify what determines ischemic lesion evolution and identify
new potential targets for development of new treatments to increase the
change of better clinical recovery. The application of the metamorphosis
model to scattered and solitary perfusion stroke lesions has led us to a set of
observations: some are partly consistent with stroke literature such as the role
that perfusion values play in determining final tissue fate, others pave the way
for a paradigm shift with regard to the ‘universality’ of perfusion values in
determining final tissue fate. We have also presented a novel powerful analysis
tool (metamorphic residual map) for extracting both kinetic and intensity
features from time-series imaging. Future work includes integrating new
clinical variables into the longitudinal metamorphosis model and validating
of our findings in larger datasets using different perfusion maps. Moreover,
this model and algorithm are not specific to stroke lesions and could be
used to model other brain diseases evolution with topology change such as
hematoma or white matter hyperintensities or tumors.
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